Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aesthetic Medical International Holdings Group Limited (PAIYY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: PAIYY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -85.57% | Avg. Invested days 10 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.73M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.24 | 52 Weeks Range 0.12 - 0.60 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 0.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.64% | Operating Margin (TTM) 3.47% |
Management Effectiveness
Return on Assets (TTM) -0.48% | Return on Equity (TTM) -116.69% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 25795809 | Price to Sales(TTM) 0.02 |
Enterprise Value 25795809 | Price to Sales(TTM) 0.02 | ||
Enterprise Value to Revenue 0.24 | Enterprise Value to EBITDA 2.52 | Shares Outstanding 48687600 | Shares Floating 17986168 |
Shares Outstanding 48687600 | Shares Floating 17986168 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aesthetic Medical International Holdings Group Limited
Company Overview
History and Background
Aesthetic Medical International Holdings Group Limited, founded in 2005, is a leading provider of aesthetic medical services in China. It has grown through organic expansion and acquisitions, focusing on non-surgical and surgical aesthetic procedures.
Core Business Areas
- Surgical Aesthetic Services: Includes cosmetic surgery procedures such as rhinoplasty, breast augmentation, and liposuction.
- Non-Surgical Aesthetic Services: Offers treatments like injectables (Botox, fillers), laser treatments, and skin rejuvenation therapies.
- Medical Cosmeceuticals and Other Services: Sale of skincare products and other related services.
Leadership and Structure
The company is led by a board of directors and a management team with expertise in the aesthetic medical industry. The organizational structure is hierarchical, with regional and clinic-level management.
Top Products and Market Share
Key Offerings
- Injectables (Botox, Fillers): Non-surgical treatments for wrinkle reduction and facial contouring. Competitors include Allergan, Merz Pharma, and Galderma. Revenue data is not publicly broken down for individual product lines.
- Laser Treatments: Laser-based therapies for skin rejuvenation, hair removal, and pigmentation correction. Competitors include Cynosure and Lumenis. Revenue data is not publicly broken down for individual product lines.
- Cosmetic Surgery: Surgical procedures like rhinoplasty and breast augmentation. Competitors are other plastic surgery clinics and hospitals. Revenue data is not publicly broken down for individual product lines.
Market Dynamics
Industry Overview
The aesthetic medical services market in China is experiencing rapid growth, driven by increasing disposable incomes and a growing emphasis on personal appearance. The market is fragmented, with numerous players ranging from small clinics to large hospital chains.
Positioning
Aesthetic Medical International Holdings Group Limited is a leading player in the Chinese aesthetic medical market, with a focus on quality and safety. It has a strong brand reputation and a wide network of clinics.
Total Addressable Market (TAM)
The Chinese aesthetic medical market is estimated to be worth billions of USD annually. Aesthetic Medical International Holdings Group Limited is positioned to capture a significant share of this market through its extensive clinic network and brand recognition.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Extensive clinic network
- Experienced medical professionals
- Focus on quality and safety
Weaknesses
- Geographic concentration in China
- Reliance on key medical personnel
- Exposure to regulatory changes
- Competition from other aesthetic medical providers
Opportunities
- Expansion into new geographic markets
- Development of new services and products
- Strategic acquisitions
- Increased demand for aesthetic medical services
Threats
- Intensified competition
- Adverse regulatory changes
- Economic downturn
- Negative publicity
Competitors and Market Share
Key Competitors
- Allergan (ABBV)
- Galderma
- Merz Pharma
Competitive Landscape
Aesthetic Medical International Holdings Group Limited faces intense competition from both domestic and international players. Its competitive advantage lies in its brand recognition and extensive clinic network in China. The company went private in 2020.
Major Acquisitions
Pengcheng Hospital
- Year: 2017
- Acquisition Price (USD millions): 52.8
- Strategic Rationale: Expansion of clinic network and service offerings.
Growth Trajectory and Initiatives
Historical Growth: Historical growth was strong, driven by the expanding Chinese market and the company's strategic initiatives. Growth trends are difficult to assess due to going private.
Future Projections: Future projections are not available due to going private.
Recent Initiatives: Recent strategic initiatives are not publicly available due to going private.
Summary
Aesthetic Medical International Holdings Group Limited was once a strong player in the Chinese aesthetic medical market but went private in 2020. Before going private, the company benefited from a strong brand and an extensive network. Intensified competition and regulatory changes posed challenges. Given it is not on the US stock market anymore its analysis is hard to quantify. It is difficult to access publicly available information to determine the current performance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Press Releases (prior to delisting)
- Industry Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and may not be entirely accurate due to the company going private. Financial data may be outdated. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aesthetic Medical International Holdings Group Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2019-10-25 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1309 | Website https://ir.aihgroup.net |
Full time employees 1309 | Website https://ir.aihgroup.net | ||
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.